In vivo therapy with anti-programmed cell death-1 Ab decreased ARG1+ TAM populations [39], which is consistent with another study on the TAM-mediated inhibition of tumor immunity via the expression of PD-1 [38]. The gene discussed is ARG1; the disease is neoplasm.